●Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study (pubmed )https://pubmed.ncbi.nlm.nih.gov/35864269/ (journal) https://link.springer.com/article/10.1007/s00432-022-04206-8 (…
